Genome transfer for the prevention of female infertility caused by maternal gene mutation
Poor oocyte quality is associated with early embryo developmental arrest and infertility. Maternal gene plays crucial roles in the regulation of oocyte maturation, and its mutation is a common cause of female infertility. However, how to improve oocyte quality and develop effective therapy for maternal gene mutation remains elusive. Here, we use Zar1 as an example to assess the feasibility of genome transfer to cure maternal gene mutation-caused female infertility. We first discover that cytoplasmic deficiency primarily leads to Zar1-null embryo developmental arrest by disturbing maternal transcript degradation and minor zygotic genome activation (ZGA) during the maternal-zygotic transition.
We next perform genome transfer at the oocyte (spindle transfer or polar body transfer) and zygote (early pronuclear transfer or late pronuclear transfer) stages to validate the feasibility of preventing Zar1 mutation-caused infertility. We finally demonstrate that genome transfer either at the oocyte or at the early pronuclear stage can support normal preimplantation embryo development and produce live offspring. Moreover, those pups grow to adulthood and show normal fertility. Therefore, our findings provide an effective basis of therapies for the treatment of female infertility caused by maternal gene mutation.
HIV-1 p24 recombinant antigen |
|||
8909 | Virostat | 100 ug | EUR 608.1 |
Description: This is HIV-1 p24 recombinant antigen for ELISA,WB. |
HIV-1 p24 recombinant antigen. |
|||
00174-V | Virogen | 1 MG | EUR 850 |
HIV-1 p24 recombinant antigen, |
|||
00174-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen, |
|||
00174-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen. |
|||
00174-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen. |
|||
MBS485187-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV-1 p24 recombinant antigen. |
|||
MBS485187-1mg | MyBiosource | 1mg | EUR 1300 |
HIV-1 p24 recombinant antigen. |
|||
MBS485187-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
Human HIV-1 And HIV-2 Plus P24 Antigen Fourth-Generation (HIV p24 antigen) ELISA Kit |
|||
abx257575-96tests | Abbexa | 96 tests | EUR 764.4 |
HIV-1 gag p24 antigen (RECOMBINANT) |
|||
HI1A-720-4 | Austral Biologicals | 50ug | EUR 295 |
HIV-1 gag p24 antigen (RECOMBINANT) |
|||
HI1A-720-5 | Austral Biologicals | 100ug | EUR 495 |
Astrovirus Antigen (Type 1) |
|||
AS02-1000 | The Native Antigen Company | 1.0 | EUR 1654.65 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
Astrovirus Antigen (Type 1) |
|||
AS02-200 | The Native Antigen Company | 0.2 | EUR 442.69 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
Recombinant HIV-1 p24 Core Antigen |
|||
HIV-277 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V | Virogen | 1 MG | EUR 850 |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV-1 p17-p24 recombinant antigen. |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-1mg | MyBiosource | 1mg | EUR 1300 |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
HIV type 1 P24 |
|||
DAG1520 | Creative Diagnostics | 100 µg | EUR 972 |
HIV Type-1 p24 Antibody |
|||
V2344-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load. |
HIV Type-1 p24 Antibody |
|||
V2344-20UG | NSJ Bioreagents | 20 ug | EUR 186.15 |
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load. |
HIV Type-1 p24 Antibody |
|||
V2344CF488-100T | NSJ Bioreagents | 100 Tests | EUR 424.15 |
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load. |
HIV Type-1 p24 Antibody |
|||
V2344SAF-100UG | NSJ Bioreagents | 100 ug | EUR 424.15 |
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V | Virogen | 1 MG | EUR 850 |
HIV 1 p24 core recombinant antigen |
|||
00177-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-1mg | MyBiosource | 1mg | EUR 1300 |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
Antibody against HIV P24 antigen |
|||
MBS478168-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478168-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478168-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478168-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478168-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478169-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478169-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478169-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478169-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478169-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478170-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478170-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478170-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478170-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478170-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478171-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478171-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478171-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478171-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478171-5mg | MyBiosource | 5mg | EUR 840 |
Recombinant HIV-1 p24 Antigen, His-tagged |
|||
HIV-276 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Recombinant HIV-1 p24 Antigen, His-tagged |
|||
HIV-281 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV type 1 P24 [GST] |
|||
DAG1516 | Creative Diagnostics | 100 µg | EUR 774 |
HIV type 1 P24 [His] |
|||
DAG1518 | Creative Diagnostics | 100 µg | EUR 774 |
HIV type 1 P24 [His] |
|||
DAG1799 | Creative Diagnostics | 50 ug | EUR 2017.2 |
HIV type 1 P24 [His] |
|||
DAG2375 | Creative Diagnostics | 100 µg | EUR 868.8 |
HIV type 1 P24 [His] |
|||
DAG2377 | Creative Diagnostics | 100 µg | EUR 868.8 |
HIV-1 gag p24 antigen IgG fraction (monoclonal) |
|||
HI1M-721-5 | Austral Biologicals | 100ug | EUR 425 |
HIV type 1 p24 [FITC] |
|||
DAGH004 | Creative Diagnostics | 50 Tests | EUR 1112.4 |
HIV type 1 P24 [Biotin] |
|||
DAG1519 | Creative Diagnostics | 100 µg | EUR 972 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-500 | The Native Antigen Company | 0.5 | EUR 671.04 |
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
HIV type O envelope antigen |
|||
00178-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. |
HIV type O envelope antigen |
|||
00178-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. |
HIV-P24 antigen array kit |
|||
VArk-Lsx001 | Creative Biolabs | unit | Ask for price |
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood. |
Recombinant HIV type 1 gp41 Antigen, Coating |
|||
DAG-WT1177 | Creative Diagnostics | 1 mg | EUR 420 |
Description: Recombinant |
Recombinant HIV type 1 gp41 Antigen, Detection |
|||
DAG-WT1178 | Creative Diagnostics | 1 mg | EUR 420 |
Description: Recombinant |
HIV type 1 P24 (p24HXBc2) [His] |
|||
DAG2378 | Creative Diagnostics | 100 µg | EUR 1095.6 |
Recombinant HIV-1 p24 Antigen, GST-tagged, HRP-Labled |
|||
HIV-282 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV type 1 P24 (CN54) [His] |
|||
DAG2380 | Creative Diagnostics | 100 µg | EUR 1095.6 |
HIV type 1 P24 (HXBc2) [His] |
|||
DAG2376 | Creative Diagnostics | 100 µg | EUR 868.8 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
|||
MBS568670-1mg | MyBiosource | 1mg | EUR 2175 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
|||
MBS568670-5x1mg | MyBiosource | 5x1mg | EUR 9585 |
Recombinant HIV-1 gag p17 and p24 Antigen, GST-tagged |
|||
PT2-332 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-100 | The Native Antigen Company | 0.1 | EUR 496.27 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-500 | The Native Antigen Company | 0.5 | EUR 1363.78 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
|||
REC31706-100 | The Native Antigen Company | 0.1 | EUR 457.08 |
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
|||
REC31706-500 | The Native Antigen Company | 0.5 | EUR 1167.82 |
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Human Immunodeficiency Virus type 1 (HIV-1) Gag-p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105661-002mL | MyBiosource | 0.02mL | EUR 185 |
Human Immunodeficiency Virus type 1 (HIV-1) Gag-p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105661-01mL | MyBiosource | 0.1mL | EUR 415 |
Human Immunodeficiency Virus type 1 (HIV-1) Gag-p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105661-5x01mL | MyBiosource | 5x0.1mL | EUR 1710 |
Recombinant HIV-1 p24 gag Antigen, beta-galactosidase-tagged |
|||
HIV-278 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype
Dimethyl fumarate (DMF) has emerged as a first-line treatment for the relapsing-remitting multiple sclerosis (RRMS) subtype. It is hypothesized that DMF has anti-inflammatory and antioxidant effects although mechanisms are not fully understood. This study used RNA-seq to profile gene expression responses to DMF in cultured astrocytes. Responses were compared with those of isosorbide di-(methyl fumarate) (IDMF), a newly designed fumarate that may partially replicate DMF activity with fewer adverse effects. Both compounds altered the expression of MS-associated genes, including those near MS susceptibility loci and genes dysregulated in MS patient astrocytes.
The shared DMF/IDMF transcriptome response involved altered expression of antioxidant genes (e.g., HMOX1) and genes linked to extracellular matrix integrity (TIMP3, MMP9) and migration of pro-inflammatory cells into CNS (CCL2). IDMF-specific transcriptome responses included down-regulation of mitotic genes associated with a proliferative reactive astrocyte phenotype (ICAM1) and repression of genes encoding NF-kappaB subunits (NFKB2, RELA, RELB) and NF-kappaB targets (NCAPG, CXCL1, OAS3). Overall, these results identify astrocyte-centered mechanisms that may contribute to the established efficacy of DMF as an RRMS treatment. Furthermore, our findings support a rationale for further studies of IDMF as a novel fumarate, which may have unique suppressive effects on astrocyte reactivity and glial scar formation. [200 words].
Changes in peripheral blood oxidative stress markers and hepatic gene expression related to oxidative stress in Holstein cows with and without subacute ruminal acidosis during the periparturient period
We investigated changes in peripheral blood metabolites, oxidative stress markers (malondialdehyde, potential antioxidant capacity, and glutathione peroxidase [GPX]), and hepatic gene expression related to oxidative stress in Holstein cows with and without subacute ruminal acidosis (SARA) during the periparturient period. Eighteen multiparous Holstein cows were categorized into SARA (n=9) or non-SARA (n=9) groups depending on whether they developed SARA; reticulo-ruminal pH was <5.6 for more than 3 hr per day, during the 2 weeks after parturition. Blood and liver tissue samples were collected 3 weeks prepartum and 2 and 6 weeks postpartum, with an additional blood sample collected 0 and 4 weeks postpartum.
Blood aspartate transaminase (AST) and nonesterified fatty acid (NEFA) increased significantly (P<0.05) after parturition in both groups. GPX activity decreased gradually after parturition in the SARA group. In the SARA group, gene expression of GPX 1 and microsomal glutathione S-transferase 3 (MGST3) decreased significantly (P<0.05), and expression of metallothionein 2A increased significantly (P<0.05) after parturition in the SARA group. Superoxide dismutase 1 and MGST3 decreased significantly (P<0.05) 2 weeks postpartum in the non-SARA group. Gene expression related to oxidative stress was negatively correlated with AST, NEFA and total ketone body levels. Therefore, the hepatic gene expression related to oxidative stress might change associated with a negative energy balance, and might relate the high oxidative stress in the SARA group during periparturient period.
PSMB8 Antibody |
|||
E94054 | EnoGene | 100μg | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E97340 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E314816 | EnoGene | 100ug/200ul | EUR 295 |
Description: Available in various conjugation types. |
PSMB8 antibody |
|||
70R-13550 | Fitzgerald | 100 ul | EUR 550 |
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
|||
70R-19589 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
|||
1-CSB-PA116429 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PSMB8 antibody |
|||
BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Conjugated Antibody |
|||
C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Antibody (N-term) |
|||
MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
1-CSB-PA018886LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
1-CSB-PA018886LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
OACD05288-1ML - PSMB8 Antibody |
|||
OACD05288-1ML | Aviva Systems Biology | 1ml | EUR 649 |
OACD05289-1ML - PSMB8 Antibody |
|||
OACD05289-1ML | Aviva Systems Biology | 1ml | EUR 659 |
OACD05290-1ML - PSMB8 Antibody |
|||
OACD05290-1ML | Aviva Systems Biology | 1ml | EUR 639 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
OAAN02231-50UL - PSMB8 Antibody |
|||
OAAN02231-50UL | Aviva Systems Biology | 50ul | EUR 149 |
PSMB8 Antibody, Biotin conjugated |
|||
1-CSB-PA018886LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
OACD05288-100UL - PSMB8 Antibody |
|||
OACD05288-100UL | Aviva Systems Biology | 100ul | EUR 199 |
OACD05289-100UL - PSMB8 Antibody |
|||
OACD05289-100UL | Aviva Systems Biology | 100ul | EUR 189 |
OACD05290-100UL - PSMB8 Antibody |
|||
OACD05290-100UL | Aviva Systems Biology | 100ul | EUR 189 |
OAAN02231-100UL - PSMB8 Antibody |
|||
OAAN02231-100UL | Aviva Systems Biology | 100ul | EUR 249 |
OAAN02231-200UL - PSMB8 Antibody |
|||
OAAN02231-200UL | Aviva Systems Biology | 200ul | EUR 389 |
OAEB02189-100UG - PSMB8 Antibody |
|||
OAEB02189-100UG | Aviva Systems Biology | 100ug | EUR 349 |
OAGA01026-100UL - PSMB8 antibody |
|||
OAGA01026-100UL | Aviva Systems Biology | 100ul | EUR 369 |